CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $5.1 million in its fourth quarter.
The Chicago-based company said it had a loss of 3 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.
The company posted revenue of $60.1 million in the period.
For the year, the company reported a loss of $54.8 million, or 37 cents per share. Revenue was reported as $203.1 million.
Xeris Biopharma expects full-year revenue in the range of $255 million to $275 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
